Advanced search
Publication Cover
Clinical Lipidology Volume 6, 2011 - Issue 2
Submit an article Journal homepage
1,877
Views
33
CrossRef citations to date
0
Altmetric
Reviews

Role of different dietary saturated fatty acids for cardiometabolic risk

David IggmanDepartment of Public Health and Caring Sciences, Uppsala university, Clinical Nutrition & Metabolism, Uppsala Science Park, 75185, Uppsala,SwedenCorrespondence[email protected]
&
Ulf RisérusDepartment of Public Health and Caring Sciences, Uppsala university, Clinical Nutrition & Metabolism, Uppsala Science Park, 75185, Uppsala,Sweden
Pages 209-223 | Published online: 18 Jan 2017

  • Hodson L, Skeaff CM, Fielding BA: Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 47, 348–380 (2008).
  • Baylin A, Kabagambe EK, Siles X, Campos H: Adipose tissue biomarkers of fatty acid intake. Am. J. Clin. Nutr. 76, 750–757 (2002).
  • Saadatian-Elahi M, Slimani N, Chajes V et al.: Plasma phospholipid fatty acid profiles and their association with food intakes: results from a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition. Am. J. Clin. Nutr. 89, 331–346 (2009).
  • Demonstrates the less than straightforward relationships between food intake and circulating fatty acids on an ecological level.
  • Warensjo E, Jansson JH, Berglund L et al.: Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case–control study. Br. J. Nutr. 91, 635–642 (2004).
  • Wolk A, Furuheim M, Vessby B: Fatty acid composition of adipose tissue and serum lipids are valid biological markers of dairy fat intake in men. J. Nutr. 131, 828–833 (2001).
  • Rioux V, Legrand P: Saturated fatty acids: simple molecular structures with complex cellular functions. Curr. Opin. Clin. Nutr. Metab. Care 10, 752–758 (2007).
  • Highlights the different metabolic effects of individual saturated fatty acids (SFA).
  • Warensjo E, Riserus U, Gustafsson IB, Mohsen R, Cederholm T, Vessby B: Effects of saturated and unsaturated fatty acids on estimated desaturase activities during a controlled dietary intervention. Nutr. Metab. Cardiovasc. Dis. 18, 683–690 (2008).
  • Riserus U, Arnlov J, Berglund L: Long-term predictors of insulin resistance: role of lifestyle and metabolic factors in middle-aged men. Diabetes Care 30, 2928–2933 (2007).
  • Micha R, Mozaffarian D: Trans fatty acids: effects on cardiometabolic health and implications for policy. Prostaglandins Leukot. Essent. Fatty Acids 79, 147–152 (2008). 10 van Dijk SJ, Feskens EJ, Bos MB et al.: A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome. Am. J. Clin. Nutr. 90, 1656–1664 (2009).
  • Siskind LJ: Mitochondrial ceramide and the induction of apoptosis. J. Bioenerg. Biomembr. 37, 143–153 (2005).
  • Stiban J, Fistere D, Colombini M: Dihydroceramide hinders ceramide channel formation: implications on apoptosis. Apoptosis 11, 773–780 (2006).
  • Kim JK: Fat uses a TOLL-road to connect inflammation and diabetes. Cell Metab. 4, 417–419 (2006).
  • Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS: TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015–3025 (2006).
  • Erridge C, Samani NJ: Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler. Thromb. Vasc. Biol. 29, 1944–1949 (2009).
  • Reynoso R, Salgado LM, Calderon V: High levels of palmitic acid lead to insulin resistance due to changes in the level of phosphorylation of the insulin receptor and insulin receptor substrate-1. Mol. Cell. Biochem. 246, 155–162 (2003).
  • Kennedy A, Martinez K, Chuang CC, LaPoint K, McIntosh M: Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications. J. Nutr. 139, 1–4 (2009). 18 Insulin Resistance. Childhood Precursors and Adult Disease. Zeitler P, Nadeau K (Eds). Humana Press, NY, USA (2008).
  • Komatsu M, Sharp GW: Palmitate and myristate selectively mimic the effect of glucose in augmenting insulin release in the absence of extracellular Ca2+. Diabetes 47, 352–357 (1998).
  • Unger RH: Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44, 863–870 (1995).
  • Poitout V, Robertson RP: Glucolipotoxicity: fuel excess and b-cell dysfunction. Endocr. Rev. 29, 351–366 (2008).
  • Manco M, Calvani M, Mingrone G: Effects of dietary fatty acids on insulin sensitivity and secretion. Diabetes Obes. Metab. 6, 402–413 (2004).
  • Giacca A, Xiao C, Oprescu AI, Carpentier AC, Lewis GF: Lipid-induced pancreatic b-cell dysfunction: focus on in vivo studies. Am. J. Physiol. Endocrinol. Metab. 300(2), E255–E262 (2011).
  • Nolan CJ, Madiraju MS, Delghingaro?Augusto V, Peyot ML, Prentki M: Fatty acid signaling in the b-cell and insulin secretion. Diabetes 55(Suppl. 2), S16–S23 (2006).
  • Bjermo H, Riserus U: Role of hepatic desaturases in obesity-related metabolic disorders. Curr. Opin. Clin. Nutr. Metab. Care 13, 703–708 (2010).
  • Warensjo E, Sundstrom J, Vessby B, Cederholm T, Riserus U: Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study. Am. J. Clin. Nutr. 88, 203–209 (2008).
  • Dobrzyn P, Dobrzyn A, Miyazaki M, Ntambi JM: Loss of stearoyl-CoA desaturase 1 rescues cardiac function in obese leptin-deficient mice. J. Lipid Res. 51, 2202–2210 (2010).
  • Degirolamo C, Shelness GS, Rudel LL: LDL cholesteryl oleate as a predictor for atherosclerosis: evidence from human and animal studies on dietary fat. J. Lipid Res. 50(Suppl.), S434–S439 (2009).
  • Lin J, Yang R, Tarr PT et al.: Hyperlipidemic effects of dietary saturated fats mediated through PGC-1b coactivation of SREBP. Cell 120, 261–273 (2005).
  • Describes one mechanism through which SFA (especially 16:0) raises serum cholesterol.
  • Cummings JH: Short chain fatty acids in the human colon. Gut 22, 763–779 (1981).
  • Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K: Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim. Biophys. Acta 1801(11), 1175–1183 (2010).
  • Young GP, Hu Y, Le Leu RK, Nyskohus L: Dietary fibre and colorectal cancer: a model for environment–gene interactions. Mol. Nutr. Food Res. 49, 571–584 (2005).
  • Sengupta S, Muir JG, Gibson PR: Does butyrate protect from colorectal cancer? J. Gastroenterol. Hepatol. 21, 209–218 (2006).
  • Maslowski KM, Vieira AT, Ng A et al.: Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282–1286 (2009).
  • Chen J, Ghazawi FM, Bakkar W, Li Q: Valproic acid and butyrate induce apoptosis in human cancer cells through inhibition of gene expression of Akt/protein kinase B. Mol. Cancer 5, 71 (2006).
  • Belakavadi M, Prabhakar BT, Salimath BP: Purification and characterization of butyrate-induced protein phosphatase involved in apoptosis of Ehrlich ascites tumor cells. Biochim. Biophys. Acta 1770, 39–47 (2007).
  • Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ: Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27, 104–119 (2008).
  • Seaton TB, Welle SL, Warenko MK, Campbell RG: Thermic effect of medium?chain and long-chain triglycerides in man. Am. J. Clin. Nutr. 44, 630–634 (1986).
  • Tsuji H, Kasai M, Takeuchi H, Nakamura M, Okazaki M, Kondo K: Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women. J. Nutr. 131, 2853–2859 (2001).
  • Batovska DI, Todorova IT, Tsvetkova IV, Najdenski HM: Antibacterial study of the medium chain fatty acids and their 1-monoglycerides: individual effects and synergistic relationships. Pol. J. Microbiol. 58, 43–47 (2009).
  • Li Q, Estes JD, Schlievert PM et al.: Glycerol monolaurate prevents mucosal SIV transmission. Nature 458, 1034–1038 (2009).
  • German JB, Dillard CJ: Saturated fats: a perspective from lactation and milk composition. Lipids 45, 915–923 (2010).
  • Isaacs CE: Human milk inactivates pathogens individually, additively, and synergistically. J. Nutr. 135, 1286–1288 (2005).
  • Legrand P, Rioux V: The complex and important cellular and metabolic functions of saturated fatty acids. Lipids 45, 941–946 (2010).
  • Rioux V, Catheline D, Bouriel M, Legrand P: Dietary myristic acid at physiologically relevant levels increases the tissue content of C20:5 n-3 and C20:3 n-6 in the rat. Reprod. Nutr. Dev. 45, 599–612 (2005).
  • Dabadie H, Peuchant E, Bernard M, LeRuyet P, Mendy F: Moderate intake of myristic acid in sn-2 position has beneficial lipidic effects and enhances DHA of cholesteryl esters in an interventional study. J. Nutr. Biochem. 16, 375–382 (2005).
  • Dabadie H, Motta C, Peuchant E, LeRuyet P, Mendy F: Variations in daily intakes of myristic and a-linolenic acids in sn-2 position modify lipid profile and red blood cell membrane fluidity. Br. J. Nutr. 96, 283–289 (2006).
  • Khera AV, Cuchel M, de la Llera-Moya M et al.: Cholesterol efflux capacity, highdensity lipoprotein function, and atherosclerosis. N. Engl. J. Med. 364, 127–135 (2011).
  • Demonstrates that efflux capacity is not strongly associated with serum levels of HDL-C.
  • Cromwell WC, Otvos JD, Keyes MJ et al.: LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study – implications for LDL management. J. Clin. Lipidol. 1, 583–592 (2007).
  • Mensink RP, Zock PL, Kester AD, Katan MB: Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 77, 1146–1155 (2003).
  • Sacks FM, Katan M: Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am. J. Med. 113(Suppl. 9B), 13S–24S (2002).
  • Berneis KK, Krauss RM: Metabolic origins and clinical significance of LDL heterogeneity. J. Lipid Res. 43, 1363–1379 (2002).
  • Younis N, Charlton-Menys V, Sharma R, Soran H, Durrington PN: Glycation of LDL in non-diabetic people: small dense LDL is preferentially glycated both in vivo and in vitro. Atherosclerosis 202, 162–168 (2009).
  • Musunuru K: Atherogenic dyslipidemia: cardiovascular risk and dietary intervention. Lipids 45, 907–914 (2010).
  • Lewington S, Whitlock G, Clarke R et al.: Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370, 1829–1839 (2007).
  • Di Angelantonio E, Sarwar N, Perry P et al.: Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302, 1993–2000 (2009).
  • Micha R, Mozaffarian D: Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids 45, 893–905 (2010).
  • Koh-Banerjee P, Chu NF, Spiegelman D et al.: Prospective study of the association of changes in dietary intake, physical activity, alcohol consumption, and smoking with 9-y gain in waist circumference among 16 587 US men. Am. J. Clin. Nutr. 78, 719–727 (2003).
  • Field AE, Willett WC, Lissner L, Colditz GA: Dietary fat and weight gain among women in the Nurses’ Health Study. Obesity (Silver Spring) 15, 967–976 (2007).
  • Keogh JB, Grieger JA, Noakes M, Clifton PM: Flow-mediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet. Arterioscler. Thromb. Vasc. Biol. 25, 1274–1279 (2005).
  • Harvey KA, Walker CL, Pavlina TM, Xu Z, Zaloga GP, Siddiqui RA: Long-chain saturated fatty acids induce proinflammatory responses and impact endothelial cell growth. Clin. Nutr. 29, 492–500 (2010).
  • Delgado-Lista J, Garcia-Rios A, Perez?Martinez P et al.: Gene variations of nitric oxide synthase regulate the effects of a saturated fat rich meal on endothelial function. Clin. Nutr. (2010) (Epub ahead of print).
  • Jimenez-Gomez Y, Lopez-Miranda J, Blanco-Colio LM et al.: Olive oil and walnut breakfasts reduce the postprandial inflammatory response in mononuclear cells compared with a butter breakfast in healthy men. Atherosclerosis 204, E70–E76 (2009).
  • Kris-Etherton PM, Yu S: Individual fatty acid effects on plasma lipids and lipoproteins: human studies. Am. J. Clin. Nutr. 65, S1628–S1644 (1997).
  • Waqar AB, Koike T, Yu Y et al.: High-fat diet without excess calories induces metabolic disorders and enhances atherosclerosis in rabbits. Atherosclerosis 213(1), 148–155 (2010).
  • Nicholls SJ, Lundman P, Harmer JA et al.: Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function. J. Am. Coll. Cardiol. 48, 715–720 (2006).
  • Masterjohn C: The anti-inflammatory properties of safflower oil and coconut oil may be mediated by their respective concentrations of vitamin E. J. Am. Coll. Cardiol. 49, 1825–1826 (2007).
  • Sanders TA: Fat and fatty acid intake and metabolic effects in the human body. Ann. Nutr. Metab. 55, 162–172 (2009).
  • Hunter JE, Zhang J, Kris-Etherton PM: Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am. J. Clin. Nutr. 91, 46–63 (2010).
  • Aro A, Jauhiainen M, Partanen R, Salminen I, Mutanen M: Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins in healthy subjects. Am. J. Clin. Nutr. 65, 1419–1426 (1997).
  • Nimptsch K, Berg-Beckhoff G, Linseisen J: Effect of dietary fatty acid intake on prospective weight change in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition. Public Health Nutr. 13, 1636–1646 (2010).
  • Baer DJ, Judd JT, Clevidence BA, Tracy RP: Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am. J. Clin. Nutr. 79, 969–973 (2004).
  • Thijssen MA, Hornstra G, Mensink RP: Stearic, oleic, and linoleic acids have comparable effects on markers of thrombotic tendency in healthy human subjects. J. Nutr. 135, 2805–2811 (2005).
  • Kelly FD, Sinclair AJ, Mann NJ, Turner AH, Abedin L, Li D: A stearic acid-rich diet improves thrombogenic and atherogenic risk factor profiles in healthy males. Eur. J. Clin. Nutr. 55, 88–96 (2001).
  • Miller GJ: Dietary fatty acids and the haemostatic system. Atherosclerosis 179, 213–227 (2005).
  • Staiger K, Staiger H, Weigert C, Haas C, Haring HU, Kellerer M: Saturated, but not unsaturated, fatty acids induce apoptosis of human coronary artery endothelial cells via nuclear factor-kB activation. Diabetes 55, 3121–3126 (2006).
  • Hayes KC, Pronczuk A: Replacing trans fat: the argument for palm oil with a cautionary note on interesterification. J. Am. Coll. Nutr. 29, S253–S284 (2010).
  • Mente A, de Koning L, Shannon HS, Anand SS: A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch. Intern. Med. 169, 659–669 (2009).
  • Siri-Tarino PW, Sun Q, Hu FB, Krauss RM: Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am. J. Clin. Nutr. 91, 535–546 (2010).
  • Iqbal R, Anand S, Ounpuu S et al.: Dietary patterns and the risk of acute myocardial infarction in 52 countries: results of the INTERHEART study. Circulation 118, 1929–1937 (2008).
  • Valsta LM, Tapanainen H, Sundvall J et al.: Explaining the 25?year decline of serum cholesterol by dietary changes and use of lipid-lowering medication in Finland. Public Health Nutr. 13, 932–938 (2010).
  • Jakobsen MU, O’Reilly EJ, Heitmann BL et al.: Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am. J. Clin. Nutr. 89, 1425–1432 (2009).
  • Jakobsen MU, Dethlefsen C, Joensen AM et al.: Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index. Am. J. Clin. Nutr. 91, 1764–1768 (2010).
  • Astrup A, Dyerberg J, Elwood P et al.: The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Am. J. Clin. Nutr. 93(4), 684–688 (2011).
  • Mozaffarian D, Micha R, Wallace S: Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 7, E1000252 (2010).
  • Hu FB, Stampfer MJ, Manson JE et al.: Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am. J. Clin. Nutr. 70, 1001–1008 (1999).
  • First cohort study to describe different coronary heart disease risks for different SFA, indicating different patterns for 12:0–18:0 (meat) and 4:0–10:0 (dairy).
  • Laaksonen DE, Nyyssonen K, Niskanen L, Rissanen TH, Salonen JT: Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch. Intern. Med. 165, 193–199 (2005).
  • Buettner R, Parhofer KG, Woenckhaus M et al.: Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J. Mol. Endocrinol. 36, 485–501 (2006).
  • Turner N, Hariharan K, TidAng J et al.: Enhancement of muscle mitochondrial oxidative capacity and alterations in insulin action are lipid species dependent: potent tissue-specific effects of medium-chain fatty acids. Diabetes 58, 2547–2554 (2009).
  • Wang D, Wei Y, Pagliassotti MJ: Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 147, 943–951 (2006).
  • Summers LK, Fielding BA, Bradshaw HA et al.: Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 45, 369–377 (2002).
  • Schwab US, Niskanen LK, Maliranta HM, Savolainen MJ, Kesaniemi YA, Uusitupa MI: Lauric and palmitic acid-enriched diets have minimal impact on serum lipid and lipoprotein concentrations and glucose metabolism in healthy young women. J. Nutr. 125, 466–473 (1995).
  • Uusitupa M, Schwab U, Makimattila S et al.: Effects of two high-fat diets with different fatty acid compositions on glucose and lipid metabolism in healthy young women. Am. J. Clin. Nutr. 59, 1310–1316 (1994).
  • Vessby B, Unsitupa M, Hermansen K et al.: Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study. Diabetologia 44, 312–319 (2001).
  • Jebb SA, Lovegrove JA, Griffin BA et al.: Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial. Am. J. Clin. Nutr. 92, 748–758 (2010).
  • Warensjo E, Riserus U, Vessby B: Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 48, 1999–2005 (2005).
  • Roberts R, Hodson L, Dennis AL et al.: Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia 52, 882–890 (2009).
  • Iggman D, Arnlov J, Vessby B, Cederholm T, Sjogren P, Riserus U: Adipose tissue fatty acids and insulin sensitivity in elderly men. Diabetologia 53, 850–857 (2010).
  • Riserus U, Willett WC, Hu FB: Dietary fats and prevention of Type 2 diabetes. Prog. Lipid Res. 48, 44–51 (2009).
  • Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV: The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N. Engl. J. Med. 328, 238–244 (1993).
  • Manco M, Mingrone G, Greco AV et al.: Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metabolism 49, 220–224 (2000).
  • Vessby B, Tengblad S, Lithell H: Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70?year-old men. Diabetologia 37, 1044–1050 (1994).
  • Salomaa V, Ahola I, Tuomilehto J et al.: Fatty acid composition of serum cholesterol esters in different degrees of glucose intolerance: a population-based study. Metabolism 39, 1285–1291 (1990).
  • Vessby B, Aro A, Skarfors E, Berglund L, Salminen I, Lithell H The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 43, 1353–1357 (1994).
  • Laaksonen DE, Lakka TA, Lakka HM et al.: Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet. Med. 19, 456–464 (2002).
  • Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH: Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study. Am. J. Clin. Nutr. 78, 91–98 (2003).
  • Hodge AM, English DR, O’Dea K et al.: Plasma phospholipid and dietary fatty acids as predictors of Type 2 diabetes: interpreting the role of linoleic acid. Am. J. Clin. Nutr. 86, 189–197 (2007). 108 van Meijl LE, Vrolix R, Mensink RP: Dairy product consumption and the metabolic syndrome. Nutr. Res. Rev. 21, 148–157 (2008).
  • Brouwer IA, Wanders AJ, Katan MB: Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans – a quantitative review. PLoS One 5, E9434 (2010).
  • Mozaffarian D, Cao H, King IB et al.: Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann. Intern. Med. 153, 790–799 (2010).
  • Raises the question of whether trans?palmitoleic acid is a candidate for protection against diabetes and may explain some of the inconsistent associations of dairy SFA.
  • German JB, Gibson RA, Krauss RM et al.: A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk. Eur. J. Nutr. 48, 191–203 (2009).
  • Sacks FM, Campos H: Dietary therapy in hypertension. N. Engl. J. Med. 362, 2102–2112 (2010).
  • Lamarche B: Review of the effect of dairy products on non-lipid risk factors for cardiovascular disease. J. Am. Coll. Nutr. 27, 741S–746S (2008).
  • Zemel MB: The role of dairy foods in weight management. J. Am. Coll. Nutr. 24, 537S–546S (2005).
  • Ditscheid B, Keller S, Jahreis G: Cholesterol metabolism is affected by calcium phosphate supplementation in humans. J. Nutr. 135, 1678–1682 (2005).
  • Tholstrup T: Dairy products and cardiovascular disease. Curr. Opin. Lipidol. 17, 1–10 (2006).
  • Deopurkar R, Ghanim H, Friedman J et al.: Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care 33, 991–997 (2010).
  • Smedman AE, Gustafsson IB, Berglund LG, Vessby BO: Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors. Am. J. Clin. Nutr. 69, 22–29 (1999).
  • Warensjo E, Jansson JH, Cederholm T et al.: Biomarkers of milk fat and the risk of myocardial infarction in men and women: a prospective, matched case–control study. Am. J. Clin. Nutr. 92, 194–202 (2010).
  • Elwood PC, Pickering JE, Givens DI, Gallacher JE: The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids 45, 925–939 (2010).
  • Bonthuis M, Hughes MC, Ibiebele TI, Green AC, van der Pols JC: Dairy consumption and patterns of mortality of Australian adults. Eur. J. Clin. Nutr. 64, 569–577 (2010).
  • Ciccarone E, Di Castelnuovo A, Salcuni M et al.: A high-score Mediterranean dietary pattern is associated with a reduced risk of peripheral arterial disease in Italian patients with Type 2 diabetes. J. Thromb. Haemost. 1, 1744–1752 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.